baicalin has been researched along with Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Kang, Z; Ma, J; Zhai, H; Zhang, H | 1 |
| Fu, Y; Gao, J; Kang, C; Kang, M; Liu, X; Wang, L | 1 |
| Halida, B; Han, XJ; Yang, XL; Yao, YN | 1 |
3 other study(ies) available for baicalin and Parkinson Disease
| Article | Year |
|---|---|
Baicalin attenuated substantia nigra neuronal apoptosis in Parkinson's disease rats via the mTOR/AKT/GSK-3β pathway.
Topics: Animals; Apoptosis; Behavior, Animal; Disease Models, Animal; Female; Flavonoids; Glycogen Synthase Kinase 3 beta; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Substantia Nigra; TOR Serine-Threonine Kinases | 2019 |
Baicalin alleviates 6-hydroxydopamine-induced neurotoxicity in PC12 cells by down-regulation of microRNA-192-5p.
Topics: Animals; Apoptosis; Autophagy; Cell Survival; Flavonoids; MicroRNAs; Neurotoxicity Syndromes; Oxidopamine; Parkinson Disease; PC12 Cells; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; Rats; Signal Transduction; Tumor Suppressor Protein p53 | 2019 |
[Effect of Baicalin on the expression of connexin 36 in the cerebral cortex and striatum area of Parkinson's disease model rat].
Topics: Animals; Cerebral Cortex; Connexins; Corpus Striatum; Disease Models, Animal; Flavonoids; Gap Junction delta-2 Protein; Male; Mice; Parkinson Disease; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2019 |